Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

googleplus: 1 Google+ user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Google+ Dimensions citations

So far, Altmetric has seen 1 X post from an account with 161 followers.

Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103). https://t.co/zsu1m1ORft

29 Oct 2018

Reply Repost Favourite